Noctiben Mea (Doxylamine)

Doxylamine works by competitively blocking histamine H1 receptors in the brain, which reduces the wake‑promoting action of endogenous histamine. This antagonism leads to sedation and also produces anticholinergic effects that can dry nasal secretions, contributing to its use in allergy‑related symptoms.

The appropriate dose of Noctiben Mea is determined by the prescribing healthcare professional based on the product’s labeling, the patient’s age, weight, and clinical condition. Patients should follow the dosage instructions provided on the package or by their clinician and should not exceed the recommended amount.

Safety data for doxylamine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Noctiben Mea. The prescriber will decide whether the medication is appropriate.

To request Noctiben Mea, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noctiben Mea (doxylamine) and diphenhydramine belong to the same first‑generation antihistamine class and share sedative and anticholinergic properties. Doxylamine is often considered slightly more potent for sleep induction, while diphenhydramine may have a longer duration of action. Choice depends on individual response, tolerability and prescriber preference.

Store Noctiben Mea at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight. Ensure the container is tightly closed to maintain stability and potency throughout its shelf life.

Noctiben Mea is taken orally, usually with a full glass of water. It should be taken shortly before bedtime, and patients are advised not to operate machinery or drive after dosing due to its sedative effect. Follow the specific instructions on the label or those given by a healthcare professional.

The most serious adverse reactions include severe allergic responses such as anaphylaxis, cardiac arrhythmias, and rare neuropsychiatric events like hallucinations or severe confusion. If any of these occur, immediate medical attention is required. Patients should also be alert for excessive sedation that could lead to falls.

Noctiben Mea should be avoided by individuals with known hypersensitivity to doxylamine or other first‑generation antihistamines, children under the recommended age for OTC use, patients with severe hepatic impairment, and those taking monoamine oxidase inhibitors. Consultation with a healthcare professional is essential for anyone with chronic medical conditions.